KB, T., CM, A., EP, G., DN, S., JK, W., & SEP, S. (2021). A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2. Frontiers in pharmacology, 12, 685308. https://doi.org/10.3389/fphar.2021.685308
Chicago Style (17th ed.) CitationKB, Tsegay, Adeyemi CM, Gniffke EP, Sather DN, Walker JK, and Smith SEP. "A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2." Frontiers in Pharmacology 12 (2021): 685308. https://doi.org/10.3389/fphar.2021.685308.
MLA (9th ed.) CitationKB, Tsegay, et al. "A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2." Frontiers in Pharmacology, vol. 12, 2021, p. 685308, https://doi.org/10.3389/fphar.2021.685308.